LLY FY 2018 Earnings Report — Eli Lilly and Company Revenue & Financial Results | Market Cap Arena

Eli Lilly and CompanyLLY

FY 2018 Earnings

Reported February 19, 2019

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2018	Prior Q	FY 2017	QoQ Change	YoY Change
Revenue	$21.5B	—	$20.0B	—	7.6%
Op. Income	$6.0B	—	$4.2B	—	41.8%
Gross Margin	78.2%	—	77.7%	—	0.5pp
Net Margin	15.0%	—	-1.0%	—	16.1pp
EPS (Diluted)	$3.13	—	$-0.19	—	1747.4%
Free Cash Flow	$2.5B	—	$3.5B	—	-27.4%

Revenue Flow

Item	Amount
REVENUE	$21.5B
Cost of Revenue	$4.7B
GROSS PROFIT	$16.8B
R&D Expenses	$5.1B
Selling & Marketing	$0
General & Administrative	$5.7B
SG&A Expenses	$5.7B
Other Expenses	$0
Operating Expenses	$10.8B
Cost & Expenses	$15.5B
OPERATING INCOME	$6.0B
Interest Income	$159M
Interest Expense	$243M
Other Income/Expenses	-$2.3B
INCOME BEFORE TAX	$3.7B
Income Tax Expense	$530M
Net Income from Continuing Ops	$3.2B
Net Income from Discontinued Ops	$81M
Other Adjustments	$0
NET INCOME	$3.2B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$3.2B
D&A	$1.6B
EBIT	$3.9B
EBITDA	$5.5B
EPS	$3
EPS Diluted	$3

Income Statement

Item	Amount
REVENUE	$21.5B
Cost of Revenue	$4.7B
GROSS PROFIT	$16.8B
R&D Expenses	$5.1B
Selling & Marketing	$0
General & Administrative	$5.7B
SG&A Expenses	$5.7B
Other Expenses	$0
Operating Expenses	$10.8B
Cost & Expenses	$15.5B
OPERATING INCOME	$6.0B
Interest Income	$159M
Interest Expense	$243M
Other Income/Expenses	-$2.3B
INCOME BEFORE TAX	$3.7B
Income Tax Expense	$530M
Net Income from Continuing Ops	$3.2B
Net Income from Discontinued Ops	$81M
Other Adjustments	$0
NET INCOME	$3.2B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$3.2B
D&A	$1.6B
EBIT	$3.9B
EBITDA	$5.5B
EPS	$3
EPS Diluted	$3

Cash Flow Statement

Item	Amount
Net Income	$3.2B
Depreciation & Amortization	$1.6B
Stock-Based Compensation	$280M
Deferred Income Tax	$327M
Other Non-Cash Items	$2.5B
Change in Working Capital	-$2.4B
OPERATING CASH FLOW	$5.5B
Capital Expenditure	-$3.0B
Acquisitions (Net)	$0
Purchases of Investments	-$950M
Sales/Maturities of Investments	$6.1B
Other Investing Activities	-$2.0B
NET CASH FROM INVESTING	$1.9B
Net Debt Issuance	-$729M
Common Stock Repurchased	-$4.2B
Common Dividends Paid	-$2.3B
Other Financing Activities	-$373M
NET CASH FROM FINANCING	-$5.9B
FREE CASH FLOW	$2.5B
Net Change in Cash	$1.5B

Balance Sheet

Item	Amount
Cash & Equivalents	$7.3B
Short-Term Investments	$88M
Net Receivables	$5.8B
Inventory	$3.1B
Other Current Assets	$2.2B
TOTAL CURRENT ASSETS	$20.5B
PP&E (Net)	$8.0B
Goodwill	$1.4B
Intangible Assets	$1.1B
Long-Term Investments	$2.0B
Tax Assets	$2.6B
Other Non-Current Assets	$8.3B
TOTAL NON-CURRENT ASSETS	$23.4B
TOTAL ASSETS	$43.9B
Account Payables	$1.2B
Short-Term Debt	$1.1B
Deferred Revenue	$0
Other Current Liabilities	$3.7B
TOTAL CURRENT LIABILITIES	$11.9B
Long-Term Debt	$9.2B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$1.3B
Other Non-Current Liabilities	$10.6B
TOTAL NON-CURRENT LIABILITIES	$21.1B
TOTAL LIABILITIES	$33.0B
Common Stock	$661M
Additional Paid-In Capital	$6.6B
Retained Earnings	$11.4B
Treasury Stock	-$69M
Accum. Other Comp. Income	-$8.7B
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$9.8B
Minority Interest	$1.1B
TOTAL EQUITY	$10.9B
TOTAL LIABILITIES & EQUITY	$43.9B
Total Debt	$10.3B
Net Debt	$3.0B